Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Gilead Sciences' cell therapy unit Kite has reached an agreement to buy Interius BioTherapeutics, bolstering its efforts to develop therapies that do not require cells to be removed from the body ...

Ice comes in many phases (about twenty, to be exact), and scientists from the Korea Research Institute of Standards and Science (KRISS) just discovered a new one called “Ice XXI.” To study this new ...

From left, Tammie Muise, director of the clinical learning and simulation centre, and Catherine O’Brien, a standardized patient with the centre, spoke with Island Morning host Mitch Cormier during CBC ...